Student Work
Drug Synthesis for HCV
PubblicoContenuto scaricabile
open in viewerThe hepatitis C virus infects more than 170 million people worldwide. Many of the HCV deaths have been a result of drug resistance. It is essential for researchers to continue to modify the molecules to create a greater variety of drug analogues, and in doing so create one that is the solution to the HCV epidemic. HCV drug analogs that lack a side chain are less hindered and more adaptable in fighting the mutant virus; drugs of this molecular form should be focused on to produce an optimal drug response to the virus.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Publisher
- Identifier
- E-project-042612-141254
- Advisor
- Year
- 2012
- Date created
- 2012-04-26
- Resource type
- Major
- Rights statement
Relazioni
- In Collection:
Articoli
Elementi
Thumbnail | Titolo | Visibilità | Embargo Release Date | Azioni |
---|---|---|---|---|
Kathleen_Foust_MQP.pdf | Pubblico | Scaricare |
Permanent link to this page: https://digital.wpi.edu/show/p2676x443